Press Release   -

Inferior Vena Cava (IVC) Filter Market to Reach USD 1840.6 Million by 2035

According to analysts at Vantage Market Research, the Global Inferior Vena Cava (IVC) Filter Market size is worth USD 750.2 Million in 2024 and is projected to reach USD 1840.6 Million by 2035, growing at a CAGR (Compound Annual Growth Rate) of 8.5% from 2024 to 2035. Key trends of market include a shift towards retrievable filters, advancements in filter design for improved safety and efficacy, and increasing focus on patient-centric care.

Market Overview

The growing incidence of deep vein thrombosis (DVT) is a significant driver of inferior vena cava (IVC) filter market. Modern lifestyles, characterized by prolonged periods of immobility due to activities like travel, binge-watching, and extensive use of computers and mobile devices, have increased the risk of blood clots forming in the leg veins. Extended sitting or lack of physical activity disrupts normal blood flow, creating conditions conducive to clot formation. Additionally, factors such as increased stress, poor dietary habits, and rising obesity rates, which are all risk factors for DVT, have led to more individuals experiencing leg clots. 

The inferior vena cava (IVC) is a major vein responsible for carrying deoxygenated blood from the lower and middle parts of the body to the heart's right atrium. An IVC filter, a small cone-shaped device, is implanted in the vein below the kidneys to trap blood clots, or embolisms, that may travel from the deep veins in the legs to the heart and lungs. These filters have gained prominence over time, as their absence can lead to pulmonary artery blockages caused by embolisms.

Key Takeaways from the Report

• In 2024, North America dominated the market with 46.2% of market share. driven by the growing use of IVC filters for treating venous thromboembolism (VTE) and pulmonary embolism (PE), and rising prevalence of these conditions 
• Based on the Product, the Retrievable IVC Filter category accounted for significant market share of 56.5% in 2024. The segment is driven by growing preference over permanent filters due to its versatility, reduced risk of long-term complications, and advancements in retrieval techniques
• In 2024, by Application, Prevent Pulmonary Embolism (PE) dominated the largest market share. Pulmonary embolism (PE) occurs when a blood clot blocks an artery in the lung, restricting blood flow to a portion of the lung
• By End User, Hospitals led the market industry with highest market share. The segment is driven by the high volume of IVC filter implantation procedures performed in hospital settings, and supported by advanced medical infrastructure

Top Companies

• B. Braun Melsungen AG
• VENITI Inc.
• Cardinal Health Inc.
• C. R. Bard
• Braile Biomdica
• Boston Scientific Corporation
• Cook Medical
• Argon Medical Devices Inc.
• Koninklijke Philips N.V. (Philips Volcano)
• ALN

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

Argon Medical Partners with Terumo India to Expand Interventional Solutions in the Indian Market

• In May 2022, Argon Medical partnered with Terumo India, a renowned global medical technology leader, to introduce its products to the Indian market. This collaboration aims to provide comprehensive solutions across interventional radiology, vascular surgery, interventional cardiology, and clinical oncology

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.